NCT02525614

Brief Summary

The objective is to investigate the Clinical, Radiographic, Roentgen Stereophotogrammetric behaviour and patient outcome when using the Triathlon total knee prosthesis in a prospective randomized clinical trial.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2009

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
6.1 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 17, 2015

Completed
8.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 27, 2023

Completed
Last Updated

June 27, 2025

Status Verified

March 1, 2023

Enrollment Period

14.6 years

First QC Date

June 11, 2015

Last Update Submit

June 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of fixation and stability of the Triathlon total knee prosthesis by Roentgen Stereophotogrammetric Analysis (RSA)

    Assessment of fixation and stability of the Triathlon total knee prosthesis by Roentgen Stereophotogrammetric as a predictor of late mechanical loosening.

    10 years follow-up

Secondary Outcomes (4)

  • Investigation of patient outcome with radiographic analysis

    3 months, 1, 2, 5, 7 and 10 years

  • Investigation of clinical performance and patient outcome with KSS (Knee Society Score)

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years

  • Investigation of clinical performance and patient outcome with KOOS patient questionnaire

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years

  • Investigation of clinical performance and patient outcome with EQ-5D patient questionnaire

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years

Study Arms (2)

Triathlon Standard Keel

ACTIVE COMPARATOR

Triathlon Cruciate Retaining knee (CR) with a tibial keel of standard length randomised against Triathlon Cruciate Retaining knee (CR) with a tibial part with a short keel, both system will be used with cemented fixation. The short tibial keel is thought to facilitate the surgery due to easier access and better positioning possibilities. This study is aimed to evaluate if the short tibial keel will have equal fixation and migration properties as the standard keel.

Device: Triathlon Standard Keel

Triathlon Short Keel

ACTIVE COMPARATOR

Triathlon Cruciate Retaining knee (CR) with a tibial keel of standard length randomised against Triathlon Cruciate Retaining knee (CR) with a tibial part with a short keel, both system will be used with cemented fixation. The short tibial keel is thought to facilitate the surgery due to easier access and better positioning possibilities. This study is aimed to evaluate if the short tibial keel will have equal fixation and migration properties as the standard keel.

Device: Triathlon Short Keel

Interventions

Implantation of Knee Prosthesis

Triathlon Standard Keel

Implantation of Knee Prosthesis

Triathlon Short Keel

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering exclusively from OA, Stage II-V \[Ahlbäck-Traumascore, 1968 391\] will be operated.
  • Patients requiring knee prosthesis, suitable for the use of Duracon and Triathlon knee system
  • Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographical evaluations and the prescribed rehabilitation.
  • Patients who signed the Ethics Committee approved Informed Consent Form prior to surgery.

You may not qualify if:

  • Previous major knee surgery
  • Other significant disabling problems from the muscular-skeletal system than in the knees
  • Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI above 35).
  • Patients with active or suspected infection.
  • Patients with malignancy - active malignancy.
  • Patients with severe osteoporosis, Paget's disease, renal osteodystrophy.
  • Patients immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.
  • The patient has a neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device or the patient has a neurological deficit which interferes with the patient's ability to limit weight bearing or places an extreme load on the implant during the healing period.
  • Female patients planning a pregnancy during the course of the study.
  • Patients with systemic or metabolic disorders leading to progressive bone deterioration.
  • Patients, who as judged by the surgeon, are mentally incompetent or are unlikely to be compliant with the prescribed post-operative routine and follow-up evaluation schedule.
  • Patients with other severe concurrent joint involvements, which can affect their outcome.
  • Patients with other concurrent illnesses, which are likely to affect their outcome such as sickle cell anaemia, systemic lupus erythematosus or renal disease requiring dialysis.
  • Patients under the protection of law (e.g. guardianship).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Sören Toksvig-Larsen, MD

    Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2015

First Posted

August 17, 2015

Study Start

May 1, 2009

Primary Completion

November 27, 2023

Study Completion

November 27, 2023

Last Updated

June 27, 2025

Record last verified: 2023-03